Leonteq Securities AG’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Leonteq Securities AG’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,000	Closed	-$6.28K	–	1380
2022 Q3	$6.28K	Hold	4,000	–	–	﹤0.01%	1112
2022 Q2	$8.04K	Buy	4,000 +2,000	+100%	+$3.46K	﹤0.01%	1115
2022 Q1	$4.66K	Buy	2,000 +1,000	+100%	+$3.12K	﹤0.01%	1168
2021 Q4	$4.65K	Sell	1,000 -2,000	-67%	-$12.4K	﹤0.01%	1190
2021 Q3	$22.9K	Buy	3,000 +1,000	+50%	+$8.48K	﹤0.01%	956
2021 Q2	$19.4K	Sell	2,000 -3,000	-60%	-$23.9K	﹤0.01%	950
2021 Q1	$41.4K	Buy	+5,000	New	+$52.8K	﹤0.01%	806

Other funds holding SRNE

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Leonteq Securities AG's SRNE Position: Q4 2022 in Review

Leonteq Securities AG sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2022, closing a stake of 4,000 shares — an estimated $6.28K sold.

Leonteq Securities AG first reported a position in SRNE in Q1 2021 and held it in 7 quarters. The position peaked at $41.4K in Q1 2021. 221 funds tracked by Wall St. Rank hold SRNE as of Q4 2022.

Leonteq Securities AG reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Leonteq Securities AG sold 4,000 Sorrento Therapeutics, Inc. shares in Q4 2022, an estimated $6.28K.
Leonteq Securities AG first reported a position in Sorrento Therapeutics, Inc. in Q1 2021 and held it in 7 quarters.
Leonteq Securities AG's Sorrento Therapeutics, Inc. position peaked at $41.4K in Q1 2021.
221 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2022.

Based on Leonteq Securities AG's 13F filing for Q4 2022, filed 26 Mar 2026.